Your Article Summary
See Latest ArticlesDeterminants of Morbidity and Mortality of Systemic Sclerosis in Canada
Seminars in Arthritis and Rheumatism, 07/02/09
Al-Dhaher FF et al. - The authors conclude that cardiac involvement, dcSSc, and hypertension are associated with worse survival, and survival of patients with scleroderma is improving compared with older reports in the literature.
Related Articles
Measures of Response in Clinical Trials of Systemic Sclerosis: The Combined Response Index for Systemic Sclerosis (CRISS) and Outcome Measures in Pulmonary Arterial Hypertension Related to Systemic Sclerosis (EPOSS)
Journal of Rheumatology, 10/15/09
Relevance Score: 72%
Necrotizing fasciitis in a patient with overlap syndrome of systemic sclerosis and systemic lupus erythematosus
Rheumatology International, 11/16/09
Relevance Score: 68%
Aerobic Exercise is Safe and Effective in Systemic Sclerosis
International Journal of Sports Medicine, 10/14/09
Relevance Score: 67%
High frequency ultrasound measurement of digital dermal thickness in systemic sclerosis
Annals of Rheumatic Diseases, 10/23/09
Relevance Score: 66%
Mechanisms of vascular damage in systemic sclerosis
Autoimmunity, 10/02/09
Relevance Score: 66%
Today in Autoimmune/Heritable...keeping you current
Receive free subspecialty "5-minute updates" via email
Comparison of autoinflammation and autoimmunity using TRAPS and rheumatoid arthritis as prototypes of these conditions
International Journal of Clinical Rheumatology, 12/04/09
Telangiectases in scleroderma: A potential clinical marker of pulmonary arterial hypertension
Journal of Rheumatology, 12/03/09
The immunoregulatory role of vitamins A, D and E in patients with primary Sjogren's syndrome
Rheumatology, 12/01/09